Erik Magnusson

Erik Magnusson discloses dealings in 2 companies, chiefly Promore Pharma and Promore Pharma AB. The record holds 5 filings, for trades running from 25 November 2020 to 1 December 2021.

The open-market record is one-sided, with 5 purchases worth €14k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2021 alone, the filings show 2 purchases and no sales.

Half of the purchases are above €2,443 and half below. 2 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 1 December 2021, reports an open-market purchase of €6,142 in Promore Pharma AB. Most trades are made public on the day they happen. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.